<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3632">
  <stage>Registered</stage>
  <submitdate>29/08/2012</submitdate>
  <approvaldate>29/08/2012</approvaldate>
  <nctid>NCT01676870</nctid>
  <trial_identification>
    <studytitle>Exercise in Prevention of Metabolic Syndrome</studytitle>
    <scientifictitle>Exercise in Prevention of Metabolic Syndrome</scientifictitle>
    <utrn />
    <trialacronym>EX-MET</trialacronym>
    <secondaryid>2011/1230</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Metabolic Syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Research that is not of generic health relevance and not applicable to specific health categories listed above</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Hypertension</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Behaviour - 1x4 aerobic interval training
Behaviour - 4x4 aerobic interval training
Behaviour - traditional moderate training

Experimental: 1x4 aerobic interval training - 1x4min aerobic interval training (1-AIT), 3 times a week

Experimental: 4x4 aerobic interval training - 4x4min aerobic interval training (4-AIT), vigorously exercise according to today's guidelines, 3 times a week

Active Comparator: traditional moderate training - traditional moderate training (CME), moderate exercise at least 30 min, 5 days a week or more, according to today's guidelines


Behaviour: 1x4 aerobic interval training
endurance training as walking/running "uphill" 3 times/week for 16 weeks (2 supervised sessions (treadmill) and 1 at home each week) at 90% of Hfmax. Warm-up 10 min at 70% of maximal heart frequency (Hfmax), 5min cool-down.

Behaviour: 4x4 aerobic interval training
endurance training as walking/running "uphill" 3 times/week for 16 weeks (2 supervised sessions (treadmill) and 1 at home each week) at 90% of Hfmax. Warm-up 10 min at 70% of maximal heart frequency (Hfmax), 3 min active pause between each interval, 5min cool-down.

Behaviour: traditional moderate training
moderate intensity treadmill training (50-70% of HRmax) for a minimum of 30min, 5 times a week for 16 weeks (2 supervised sessions and 3 or more home).

</interventions>
    <comparator />
    <control />
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>cardiovascular risk factors constituting metabolic syndrome - Endothelial function and blood pressure, biopsies from the m. vastus lateralis, Protein and expression levels, oxidized LDL and adiponectin in blood plasma</outcome>
      <timepoint>up to 3 years</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  metabolic syndrome defined according to the IDF-criteria</inclusivecriteria>
    <inclusiveminage>30</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  unstable angina

          -  recent cardiac infarction (4weeks)

          -  uncompensated heart failure

          -  severe valvular illness

          -  pulmonary disease

          -  uncontrolled hypertension

          -  kidney failure

          -  orthopedic/neurological limitations

          -  cardiomyopathy

          -  planned operations during the research period

          -  reluctant to sign the consent form

          -  drug or alcohol abuse

          -  participants in a parallel study</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>465</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Active, not recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>31/12/2019</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>School of Human Movement Studies, University of Queensland - St Lucia</hospital>
    <postcode> - St Lucia</postcode>
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>São Paulo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ecuador</country>
      <state>Guayaquil</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Munich</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Stavanger</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Trondheim</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Norwegian University of Science and Technology</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Helse Stavanger HF</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Technische Universität München</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>The University of Queensland</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>KJ Fisiosport</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>University of Sao Paulo</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary objective of the study is to compare in a real-world setting the efficacy of
      traditional training (today's guideline, vigorously or moderate exercise) and amount of
      aerobic interval training (1-AIT) in reduction of risk factors constituting metabolic
      syndrome.

      The secondary objective is to compare the efficacy of traditional moderate training (today's
      guideline) and amount of aerobic interval training (1-AIT vs. 4-AIT) in improving aerobic
      capacity, cardiovascular function, skeletal muscle contractile function, skeletal muscle
      energy metabolism, left ventricle systolic and diastolic function at rest and right
      ventricular function.

      The investigators hypothesized that aerobic interval training would reverse features of the
      metabolic syndrome more than traditional training.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01676870</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ulrik Wisløff, PhD prof</name>
      <address>Norwegian University of Science and Technology</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>